SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Centene Corp – ‘8-K’ for 10/18/19

On:  Monday, 10/21/19, at 5:25pm ET   ·   For:  10/18/19   ·   Accession #:  1071739-19-97   ·   File #:  1-31826

Previous ‘8-K’:  ‘8-K’ on / for 9/11/19   ·   Next:  ‘8-K’ on / for 10/22/19   ·   Latest:  ‘8-K’ on / for 4/26/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/21/19  Centene Corp                      8-K:8      10/18/19   12:174K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     27K 
 9: R1          Cover                                               HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     12K 
10: XML         XBRL Instance -- form8-k_htm                         XML     15K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.CAL  XBRL Calculations -- cnc-20191021_cal                XML      6K 
 4: EX-101.DEF  XBRL Definitions -- cnc-20191021_def                 XML      8K 
 5: EX-101.LAB  XBRL Labels -- cnc-20191021_lab                      XML     66K 
 6: EX-101.PRE  XBRL Presentations -- cnc-20191021_pre               XML     36K 
 2: EX-101.SCH  XBRL Schema -- cnc-20191021                          XSD     16K 
 7: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
11: ZIP         XBRL Zipped Folder -- 0001071739-19-000097-xbrl      Zip     12K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C: 
  Document  
 i false i 0001071739 0001071739 2019-10-18 2019-10-18




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM  i 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  i October 18, 2019

 i CENTENE CORPORATION
(Exact Name of Registrant as Specified in Charter)

 i Delaware
 
 
 i 42-1406317
(State or Other Jurisdiction
of Incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 i 7700 Forsyth Boulevard,
 
 
 i St. Louis,
 i Missouri
 
 i 63105
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code: ( i 314)  i 725-4477
(Former Name or Former Address, if Changed Since Last Report): N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 i Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  i 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
 i Common stock, $0.001 Par Value
 
 i CNC
 
 i NYSE






Item 8.01 Other Events

On October 18, 2019, Centene’s Board of Directors authorized the repurchase of up to $500 million of shares of the Company's common stock (the “Increased Repurchase Amount”). Under the Increased Repurchase Amount, the Company may use some or all of the proceeds from divestitures related to the WellCare acquisition to repurchase shares. With the Increased Repurchase Amount, the Company will be able to repurchase shares or pay down debt with the divestiture proceeds, at its election. The number of shares authorized will be calculated based on the price per share of Centene’s common stock as of the date of such divestitures. 
 
The authorization to repurchase $500 million of common stock is in addition to the previously approved stock repurchase program which authorized the repurchase of up to 16.0 million shares of common stock (of which 6.7 million shares remain as of today).   

 










SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
CENTENE CORPORATION
 
 
 
 
 
Date:
By:
 
 
 
 
 
Executive Vice President & Chief Financial Officer





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:10/21/19
For Period end:10/18/19425
 List all Filings 
Top
Filing Submission 0001071739-19-000097   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 8:10:37.1am ET